Bevacizumab (Avegra®) for the treatment of gynecological cancers: joint experience of several centers

• Main Authors: A. G. Kedrova (Author), S. Е. Krasilnikov (Author), D. S. Ogay (Author), Т. A. Maksimenko (Author), V. I. Voznesenskiy (Author), А. I. Berishvili (Author), Т. A. Greyan (Author)
• Format: Book
• Published: ABV-press, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tumors of the female reproductive system are among the five most common cancers in women worldwide. Up to 60 % of these patients require chemotherapy to reduce the risk of recurrence. Currently, an additional treatment option is available for patients with advanced cancers of the female reproductive...